Bristol-Myers Squibb - About the company
Bristol-Myers Squibb is a public company based in New York City (United States), founded in 1887. It operates as a Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis. Bristol-Myers Squibb has raised an undisclosed amount in funding. The company has 508 active competitors, including 55 funded and 116 that have exited. Its top competitors include companies like Merck, Roivant Sciences and AbbVie.
Company Details
Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis. It discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. The company has multiple marketed products for cancer, HIV/AIDS, cardiovascular diseases, rheumatoid arthritis, and hepatitis. The pipeline includes multiple molecules (small molecule and biologics) at various stages of clinical trials. It was honored with the ALCF award given to organizations and individuals working towards fighting lung cancer. In 2022, the company recorded annual revenues of $45.85B and a net profit of $7.31B.
- Website
- Social
- Email ID
- @bms.com
- Phone Number
- +1
Key Metrics
Founded Year
1887
Location
New York City, United States
Stage
Public
Latest Funding Round
Investors
Ranked
64th among 508 active competitors
Annual Revenue
as on Feb 28, 2023
Employee Count
as on Dec 31, 2022
Investment & Acquisitions
Similar Companies
Merck &
Exit Details
Public
Legal entities associated with Bristol-Myers Squibb
Bristol-Myers Squibb is associated with 21 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
$25M - $100M (as on Nov 12, 2008) | 444 | 870 | ||
- | 723 | 546 | ||
Mar 12, 2018 | - | 519 | 215 | |
Mar 28, 1994 | - | 500 | 744 | |
May 30, 1994 | - | 615 | 172 | |
Aug 28, 2023 | - | 995 | 754 | |
May 04, 2023 | - | 263 | 219 | |
Jul 13, 2020 | - | 491 | 171 | |
Aug 01, 2017 | - | 678 | 772 | |
Aug 18, 2016 | - | 779 | 102 | |
Mar 04, 2013 | - | 635 | 795 | |
Feb 03, 2022 | - | 583 | 122 | |
Aug 10, 1933 | $5.24B (as on Dec 31, 2016) | 501 | 929 | |
Feb 17, 2019 | $2.51K (as on Feb 28, 2023) | 753 | 116 | |
Jun 29, 2004 | $42.2M (as on Mar 31, 2022) | 765 | 840 | |
Dec 31, 1999 | - | 627 | 227 | |
Dec 26, 999 | - | 170 | 164 | |
Dec 26, 999 | - | 447 | 530 | |
Dec 26, 999 | - | 753 | 714 | |
Aug 04, 2013 | $112M (as on Dec 31, 2017) | 985 | 853 | |
- | 732 | 234 |
Get your free copy of Bristol-Myers Squibb's company profile
Bristol-Myers Squibb's funding and investors
Bristol-Myers Squibb has raised funding over 2 rounds. Its first funding round was on Feb 21, 2017. Its latest funding round was a Grant (prize money) round on Sep 01, 2019 for an undisclosed amount. 1 investor participated in its latest round, which include Bellevue Healthcare Trust, nextGENE Capital, and Tekla Capital Management.
Bristol-Myers Squibb has 8 institutional investors including , and .
Here is the list of recent funding rounds of Bristol-Myers Squibb:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Sep 01, 2019 | Undisclosed | Grant (prize money) | 3765175 | 2905443 | |
Feb 21, 2017 | Undisclosed | Post IPO | 6020683 | 1886542 | - |
Access funding benchmarks and valuations. Sign up today!View details of Bristol-Myers Squibb's funding rounds and investors
Bristol-Myers Squibb's founders and board of directors
Bristol-Myers Squibb's employee count trend
Bristol-Myers Squibb has 160 employees as of Dec 22. The total employee count is 4.2% lower than what it was in Dec 21. Here is Bristol-Myers Squibb's employee count trend over the years:
Uncover Bristol-Myers Squibb's growth story! Sign up today!Bristol-Myers Squibb's Competitors and alternates
Top competitors of Bristol-Myers Squibb include Merck, Roivant Sciences and AbbVie. Here is the list of Top 10 competitors of Bristol-Myers Squibb, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Merck 1891, Kenilworth (United Kingdom), Public | Manufacturer of pharmaceutical products | - | , AIACÌý&²¹³¾±è;Ìý | 85/100 |
2nd |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | NovaQuest Capital Management, Sahsen VenturesÌý&²¹³¾±è;Ìý | 84/100 |
3rd | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | - | Pasadena Private Wealth, BioVariaÌý&²¹³¾±è;Ìý | 81/100 |
4th | Gilead 1987, Foster City (United States), Public | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | , IRON FinancialÌý&²¹³¾±è;Ìý | 81/100 |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | , NovaQuest Capital ManagementÌý&²¹³¾±è;Ìý | 80/100 |
6th | Abbott 1888, Libertyville (United States), Public | Developer of medical devices, generic pharmaceuticals, and nutrition products | - | nextGENE Capital, Ìý&²¹³¾±è;Ìý | 77/100 |
7th | Vertex Pharmaceuticals 1989, Boston (United States), Public | Developer of drugs for the treatment of multiple disorders | - | Bellevue Healthcare Trust, BB BiotechÌý&²¹³¾±è;Ìý | 75/100 |
8th | Developer of antibodies for treating cancer | - | Eiffel Investment Group, BioVariaÌý&²¹³¾±è;Ìý | 74/100 | |
9th | United Therapeutics 1998, Silver Spring (United States), Public | Specialty company developing treatment for chronic and life-threatening diseases | - | Oakwood Medical, First Flight Venture CenterÌý&²¹³¾±è;Ìý | 74/100 |
10th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | Capricorn Partners, MT CapitalÌý&²¹³¾±è;Ìý | 74/100 |
64th | 1887, New York City (United States), Public | Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis | - | Bellevue Healthcare Trust, nextGENE CapitalÌý&²¹³¾±è;Ìý | 48/100 |
_1586343560242.png?height=40&width=40){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bristol-Myers Squibb's competitors? Click to see the top ones
Bristol-Myers Squibb's Investments and acquisitions
Bristol-Myers Squibb has made 81 investments in companies including Be Bio and Light Horse Therapeutics. Bristol-Myers Squibb has also acquired 24 companies including 2seventy bio and RayzeBio. Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 11, 2025 | Acquisition | 2021 | Cambridge, United States | |
Jan 15, 2025 | Investments | 2020 | Cambridge, United States | |
Jan 09, 2025 | Investments | 2022 | San Diego, United States |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by Bristol-Myers Squibb
Reports related to Bristol-Myers Squibb
Here is the latest report on Bristol-Myers Squibb's sector:
View
News related to Bristol-Myers Squibb
Media has covered Bristol-Myers Squibb for a total of 375 events in the last 1 year, 192 of them have been about company updates and 21 about partnerships.
•
LexLatin•Apr 26, 2025•Bristol-Myers Squibb,
•
•
BioSpace•Apr 24, 2025•Bristol-Myers Squibb
•
EndPoints News•Apr 24, 2025•Bristol-Myers Squibb
•
MarketBeat•Apr 24, 2025•, Bristol-Myers Squibb
•
Clinical Trials Arena•Apr 23, 2025•Bristol-Myers Squibb
•
MarketBeat•Apr 20, 2025•Bristol-Myers Squibb
•
MarketBeat•Apr 20, 2025•Bristol-Myers Squibb
•
•
MarketBeat•Apr 18, 2025•Bristol-Myers Squibb,
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Bristol-Myers Squibb
When was Bristol-Myers Squibb founded?
Bristol-Myers Squibb was founded in 1887.Where is Bristol-Myers Squibb located?
Bristol-Myers Squibb is located in New York City, United States.When was the latest funding round of Bristol-Myers Squibb?
Bristol-Myers Squibb's latest funding round was on Sep 01, 2019.What is the annual revenue of Bristol-Myers Squibb?
Annual revenue of Bristol-Myers Squibb is £2.06° as on Feb 28, 2023.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Shriya Chemicals - Navi Mumbai based, 1985 founded, Unfunded company
- UAC Labs - Zurich based, 2025 founded, Unfunded company
- Classic Derma - Jaipur based, 2023 founded, Unfunded company
- Hollywood Movies - Bangkok based, 2014 founded, Unfunded company
- RoboTruck - Tokyo based, 2024 founded, Seed company
- HINE - Jarnac Champagne based, 1763 founded, Unfunded company
